Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 101

Results For "2023"

1167 News Found

USFDA completes regulatory inspection of Natco's Vizag formulation facility
News | February 06, 2023

USFDA completes regulatory inspection of Natco's Vizag formulation facility

At the end of the inspection, the facility received two observations, one on written production process control procedure and the other on investigation procedure


Umesh Kunte appointed CEO of Albert David
People | February 06, 2023

Umesh Kunte appointed CEO of Albert David

A pharma industry veteran with over three decades of experience in domestic as well as international markets


Ritesh Jain appointed CFO of Krebs Biochemicals and Industries
People | February 04, 2023

Ritesh Jain appointed CFO of Krebs Biochemicals and Industries

He is a Chartered Accountant with more than 19 years of extensive experience


Lupin launches Aptivate Champion Run for Kids
News | February 04, 2023

Lupin launches Aptivate Champion Run for Kids

Through this important initiative, Lupin Life encourages children from Mumbai, Thane, and Navi Mumbai to participate in the Aptivate Champion Run


Jubilant Ingrevia posts Q3FY23 consolidated PAT at Rs. 91.53 Cr
News | February 02, 2023

Jubilant Ingrevia posts Q3FY23 consolidated PAT at Rs. 91.53 Cr

The company has reported total income of Rs. 1165.31 crores during the period ended December 31, 2022


Hester Biosciences Q3 FY23 consolidated net profit up at Rs. 11.18 Cr
News | February 02, 2023

Hester Biosciences Q3 FY23 consolidated net profit up at Rs. 11.18 Cr

The company has reported total income of Rs. 79.33 crores during the period ended December 31, 2022


Jubilant’s Radiopharma business receives NDA approval for Technetium Mertiatide Injection
Drug Approval | February 02, 2023

Jubilant’s Radiopharma business receives NDA approval for Technetium Mertiatide Injection

The Tc 99m Mertiatide Injection is used in the diagnosis of congenital and acquired renal abnormalities


Briefs: Krsnaa Diagnostics and Solara Active Pharma Sciences
News | January 30, 2023

Briefs: Krsnaa Diagnostics and Solara Active Pharma Sciences

Krsnaa Diagnostics Limited has operationalized one diagnostics center at district hospital Male Akbarpur, Kanpur Dehat, Uttar Pradesh.


ExeGi Pharma gets clearance of IND application for EXE-346 a Live biotherapeutic biologic drug
Drug Approval | January 30, 2023

ExeGi Pharma gets clearance of IND application for EXE-346 a Live biotherapeutic biologic drug

This clearance allows the company to initiate a clinical trial for patients with an ileal pouch-anal anastomosis


Aarti Drugs Q3 FY23 revenue grows 4%
News | January 28, 2023

Aarti Drugs Q3 FY23 revenue grows 4%

Standalone Q3 FY23 revenue stood at Rs. 626.5 crore as against Rs. 594.8 crore, a growth of 5% YoY